Management tracks

Cancer company Cleave Biosciences Inc. (Burlingame, Calif) said CMO Alessandra Cesano is stepping down. Cleave hired Kanya Rajangam as VP of clinical development. Rajangam was executive director of the oncology and immuno-oncology program at Nektar Therapeutics (NASDAQ:NKTR). ...